Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In silico anticancer, antioxidant and anti-inflammatory study on GC-MS-based profiling of chloroform and hexane extracts of <i>Erigeron multiradiatus</i>.

In silico pharmacology·2026
Same author

Rocuronium Dose and First-Attempt Intubation Success in the Critically Ill: Secondary Analysis of Two Multicenter Trials.

American journal of respiratory and critical care medicine·2026
Same author

EHR Sampling Interval Bias Detection and Burden of Blood Pressure Excursions: Implications for Clinical Decision Support and Model Validity in Pediatric ECMO.

Information (Basel)·2026
Same author

Comprehensive phytochemical profiling, antibacterial, antioxidant, and <i>in-silico</i> evaluation of <i>Aster thomsonii</i> C.B. Clarke essential oil from the Kumaun Himalaya Region, Uttarakhand.

Natural product research·2026
Same author

United Global Advocacy Drives Updates to World Health Organization Essential Medicines List.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Impact of measurable residual disease on outcomes using a modified DFCI protocol for adults with BCR-ABL negative acute lymphoblastic leukemia.

Leukemia research·2026

Related Experiment Video

Updated: Feb 20, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.4K

Identifying Parkinson's Patients: A Functional Gradient Boosting Approach.

Devendra Singh Dhami1, Ameet Soni2, David Page3

  • 1Indiana University Bloomington.

Artificial Intelligence in Medicine. Conference on Artificial Intelligence in Medicine (2005- )
|October 28, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a novel machine learning method for early Parkinson's disease (PD) detection. By analyzing features from the Parkinson's Progression Markers Initiative (PPMI), it accurately classifies individuals as having PD or being healthy controls (HC).

Keywords:
Functional gradient boostingParkinson’shuman advice

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K

Related Experiment Videos

Last Updated: Feb 20, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.4K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.4K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Biomedical Data Science

Background:

  • Parkinson's disease (PD) diagnosis is challenging due to subtle, early-stage symptoms.
  • Objective identification of PD is crucial for timely intervention and management.
  • Existing diagnostic methods may lack sensitivity in early disease detection.

Purpose of the Study:

  • To develop and evaluate a machine learning (ML) model for classifying Parkinson's disease (PD) versus healthy controls (HC).
  • To leverage features from the Parkinson's Progression Markers Initiative (PPMI) study for PD classification.
  • To incorporate domain expert involvement in the feature selection process for enhanced diagnostic accuracy.

Main Methods:

  • Utilized a dataset of 1194 participants from the Parkinson's Progression Markers Initiative (PPMI) study.
  • Applied machine learning algorithms with a curated set of features.
  • Employed domain expert input for feature selection to optimize the classification model.
  • Classified subjects into two groups: Parkinson's disease (PD) and Healthy Control (HC).

Main Results:

  • Achieved state-of-the-art performance in classifying PD patients from healthy controls.
  • Demonstrated high accuracy with minimal feature engineering, suggesting an efficient approach.
  • The ML model effectively distinguished between PD and HC groups based on selected features.

Conclusions:

  • Machine learning, particularly with expert-guided feature selection, offers a powerful tool for early Parkinson's disease detection.
  • The proposed method shows significant promise for improving the diagnostic accuracy of PD.
  • This approach, validated on PPMI data, could aid in earlier identification and management of Parkinson's disease.